(UroToday.com) In this presentation, Dr. Minhaj Siddiqui elaborated on whether there is a role for biomarkers in the selection of patients for focal therapy. To date, there have been no biomarkers designed for this purpose. Dr. Siddiqui believes that in select, as of yet unclear clinical scenarios, biomarkers may hold a significant benefit. Figure 1 demonstrates the three main groups of biomarkers that were discussed in this presentation.